Insmed
INSM
$25.59
Share price
3.52%
Change (1 day)
26.87%
Change (1 year)
Categories
EPS for Insmed (INSM)
EPS in 2023 (TTM): -$5.27
According to Insmed's latest financial reports the company's current EPS (TTM) is -$5.27. In 2022 the company made an earnings per share (EPS) of -$3.90 a decrease over its 2021 EPS that were of -$3.87.
EPS history for Insmed from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$5.27 | 35.13% |
| 2022 | -$3.90 | 0.78% |
| 2021 | -$3.87 | 28.57% |
| 2020 | -$3.01 | -0.99% |
| 2019 | -$3.04 | -27.96% |
| 2018 | -$4.22 | 47.55% |
| 2017 | -$2.86 | 0.7% |
| 2016 | -$2.84 | 39.9% |
| 2015 | -$2.03 | 9.73% |
| 2014 | -$1.85 | 17.09% |
| 2013 | -$1.58 | 0.64% |
| 2012 | -$1.57 | -46.42% |
| 2011 | -$2.93 | 497.96% |
| 2010 | -$0.49 | -105.1% |
| 2009 | $9.61 | -850.78% |
| 2008 | -$1.28 | -24.71% |
| 2007 | -$1.70 | -71.67% |
| 2006 | -$6.00 | -28.57% |
| 2005 | -$8.40 | 23.53% |
| 2004 | -$6.80 | 134.48% |
| 2003 | -$2.90 | -73.64% |
| 2002 | -$11.00 | -2.65% |
| 2001 | -$11.30 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $3.74 | -170.97% | 🇨🇭 Switzerland |
 Gilead Sciences GILD | $4.39 | -183.30% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $13.09 | -348.39% | 🇺🇸 USA |
 Sarepta Therapeutics
SRPT | -$7.83 | 48.58% | 🇺🇸 USA |
 Aerie Pharmaceuticals AERI | -$0.75 | -85.77% | 🇺🇸 USA |
 Array Technologies ARRY | $0.51 | -109.68% | 🇺🇸 USA |